CD79b anticorps

N° du produit ABIN135809

L’anticorps anti-CD79b Monoclonal Souris est utilisé pour la détection de CD79b dans des échantillons de Humain. Il a été validé pour FACS.

Aperçu rapide pour CD79b anticorps (ABIN135809)

Antigène: CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD79b est non-conjugé

Application: Flow Cytometry (FACS)

Clone: CB3-1

Détail du produit anti-CD79b anticorps

Specificité: Human CD79b, Mr 37 kDa

Attributs du produit: Mouse Anti-Human CD79b-UNLB

Purification: Purified

Immunogène: Ramos B cells

Isotype: IgG1

Information d'application

Indications d'application:

• Applications: FC - Quality tested , IP - Reported in literature , WB - Reported in literature
• Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC, BIOT, PE, APC, and SPRD conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L

Volume d'échantillon: 1 mL

Restrictions: For Research Use only

Stockage

Concentration: 0.1 mg/mL

Buffer: 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

Agent conservateur: Without preservative

Conseil sur la manipulation: Each reagent is stable for the period shown on the bottle label if stored as directed.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C

Détails sur CD79b

Antigène: CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))

Autre désignation: CD79b

Sujet: CD79 is a 23/21 disulfide-linked heterodimer composed of an chain (CD79a/mb-1) and a chain (CD79b/B29) that associates non-covalently with membrane immunoglobulin to form the B cell receptor (BCR) complex. Its expression is restricted to B lymphocytes, first appearing on the surface at the pro-B cell stage and remaining through all stages of B cell differentiation prior to plasma cells. Crosslinking of the BCR leads to B cell activation.

Pathways: BCR Signaling